CPC C07D 471/04 (2013.01) [C07C 255/57 (2013.01); C07C 317/28 (2013.01); C07D 209/30 (2013.01); C07D 213/89 (2013.01); C07D 231/56 (2013.01); C07D 235/16 (2013.01); C07D 237/24 (2013.01); C07D 239/47 (2013.01); C07D 249/08 (2013.01); C07D 249/18 (2013.01); C07D 257/04 (2013.01); C07D 265/36 (2013.01); C07D 271/10 (2013.01); C07D 285/14 (2013.01); C07D 295/04 (2013.01); C07D 401/04 (2013.01); C07D 513/04 (2013.01)] | 4 Claims |
1. A compound of formula (Id-1-1):
wherein
E is —C(O)NR1—;
R1 is hydrogen, or C1-C4-alkyl;
R4-d is halo, SF5, C1-C4-alkyl, C1-C4-haloalkyl, C1-C4-alkoxy, C1-C4-haloalkoxy, C1-C4-alkylthio, or C1-C4-haloalkylthio;
is
wherein arrow represents connecting position with E, each ring corresponding to ring C may be substituted independently with 1 to 3 R9 groups which is selected from halogen, hydroxyl, C1-C4-alkyl, C1-C4-haloalkyl, C1-C4-alkoxy, or C1-C4-haloalkoxy, each ring corresponding to ring D may be substituted independently with 1 to 3 R10 groups which is selected from halogen, hydroxyl, oxo, C1-C4-alkyl, C1-C4-haloalkyl, C1-C4-alkoxy, or C1-C4-haloalkoxy,
or
a pharmaceutically acceptable salt thereof.
|